The consensus among analysts is that 1Life Healthcare, Inc. (ONEM) is an Overweight stock at the moment, with a recommendation rating of 2.1. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 3 out of 9 have rated it as a Hold, with 6 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.34.

1Life Healthcare, Inc. (ONEM) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +0% over the past 5 years. Earnings growth for 2020 is a modest -18.3% while over the next 5 years, the company’s earnings are expected to increase by 27%.

1Life Healthcare, Inc. (NASDAQ:ONEM)’s Major holders

Insiders own 9.81% of the company shares, while shares held by institutions stand at 67.36% with a share float percentage of 74.69%. Investors are also buoyed by the number of investors in a company, with 1Life Healthcare, Inc. having a total of 69 institutions that hold shares in the company. The top two institutional holders are Carlyle Group Inc. with over 28.16 Million shares worth more than $511.06 Million. As of March 30, 2020, Carlyle Group Inc. held 22.32% of shares outstanding.

The other major institutional holder is FMR, LLC, with the holding of over 9.51 Million shares as of March 30, 2020. The firm’s total holdings are worth over $172.6 Million and represent 7.54% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are BNY Mellon Small/Mid Cap Growth Fd and Fidelity Advisor Growth Opportunities Fund. As of March 30, 2020, the former fund manager holds about 1.06% shares in the company for having 1335349 shares of worth $24.24 Million while later fund manager owns 1.07 Million shares of worth $19.43 Million as of March 30, 2020, which makes it owner of about 0.85% of company’s outstanding stock.